Home  |  Contact

Cellosaurus U-BLC1 (CVCL_2738)

Cell line name U-BLC1
Synonyms UBLC1
Accession CVCL_2738
Resource Identification Initiative To cite this cell line use: U-BLC1 (RRID:CVCL_2738)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Omics: Deep RNAseq analysis.
Sequence variations TERT c.228C>T (-124C>T); in promoter (PubMed=24035680).
Disease Bladder carcinoma (NCIt: C4912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 84Y
Category Cancer cell line

PubMed=10074925; DOI=10.1002/(SICI)1097-0215(19990315)80:6<903::AID-IJC17>3.0.CO;2-8
Bruch J., Wohr G., Bruderlein S., Barbi G., Wolter H., Dixkens C., Mattfeldt T., Moller P., Paiss T., Hautmann R., Vogel W., Hameister H.
Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder.
Int. J. Cancer 80:903-910(1999)

PubMed=24367658; DOI=10.1371/journal.pone.0084411
Ross R.L., Burns J.E., Taylor C.F., Mellor P., Anderson D.H., Knowles M.A.
Identification of mutations in distinct regions of p85 alpha in urothelial cancer.
PLoS ONE 8:E84411-E84411(2013)

PubMed=24035680; DOI=10.1016/j.eururo.2013.08.057
Hurst C.D., Platt F.M., Knowles M.A.
Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine.
Eur. Urol. 65:367-369(2014)

PubMed=29732388; DOI=10.3233/BLC-180167
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)

Cell line collections ECACC; 06013102
Cell line databases/resources CCLE; UBLC1_URINARY_TRACT
Gene expression databases ArrayExpress; E-MTAB-2770
Other Wikidata; Q54973609
Polymorphism and mutation databases Cosmic; 2050467
Cosmic; 2212693